Healthline3d
Vitamin D Supplements Lower Blood Pressure in Older Adults with Obesity, Study Finds
New research finds that taking a daily vitamin D supplement may help lower blood pressure, especially for older adults with ...
Strong Financial Position and Promising Clinical Progress Justify Buy Rating for Mineralys Therapeutics
Rami Katkhuda, an analyst from LifeSci Capital, maintained the Buy rating on Mineralys Therapeutics, Inc. (MLYS – Research Report). The ...
Buy Rating on Mineralys Therapeutics Driven by Lorundrostat’s Potential in Hypertension Treatment
Mineralys Therapeutics, Inc. (MLYS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today.
marketinference3d
Mineralys Therapeutics' Focus on Hypertension and Kidney Diseases
Its clinical-stage product candidate, lorundrostat, is an orally administered, highly selective aldosterone synthase ...
Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Completed enrollment in pivotal Advance-HTN trial and anticipate topline data in March 2025 – – Completed enrollment ahead of schedule in pivotal Phase 3 Launch-HTN trial and anticipate delivering ...